A month has gone by since the last earnings report for Recursion Pharmaceuticals (RXRX). Shares have lost about 16.5% in that time frame, underperforming the S&P 500. Will the recent negative trend ...
Ms. Angwin, a contributing Opinion writer, is an investigative journalist. See more of our coverage in your search results.Encuentra más de nuestra cobertura en los resultados de búsqueda. Add The New ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer answered questions about. When a caller mentioned that Cathie Wood invested in the stock, Cramer remarked, “That’s, it’s a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果